SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-188839
Filing Date
2023-07-18
Accepted
2023-07-18 16:01:32
Documents
13
Period of Report
2023-07-13
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d533087d8k.htm   iXBRL 8-K 39408
2 EX-99.1 d533087dex991.htm EX-99.1 37056
  Complete submission text file 0001193125-23-188839.txt   212091

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA acad-20230713.xsd EX-101.SCH 2866
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE acad-20230713_lab.xml EX-101.LAB 17995
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acad-20230713_pre.xml EX-101.PRE 11272
7 EXTRACTED XBRL INSTANCE DOCUMENT d533087d8k_htm.xml XML 3407
Mailing Address 3611 VALLEY CENTRE DRIVE SUITE 300 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTRE DRIVE SUITE 300 SAN DIEGO CA 92130 858-558-2871
ACADIA PHARMACEUTICALS INC (Filer) CIK: 0001070494 (see all company filings)

IRS No.: 061376651 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50768 | Film No.: 231094257
SIC: 2834 Pharmaceutical Preparations